Foundation Healthcare IPO 3.8 times subscribed

The Singapore offering is 9.4 times subscribed, with 3,805 valid applications for 87 million shares

Tan Nai Lun
Published Tue, Jul 7, 2026 · 07:59 PM
    • Shares of Foundation Healthcare are set to begin trading on the Singapore Exchange at 9 am on Wednesday (Jul 8).
    • Shares of Foundation Healthcare are set to begin trading on the Singapore Exchange at 9 am on Wednesday (Jul 8). PHOTO: BT FILE

    [SINGAPORE] The initial public offering of Foundation Healthcare was 3.8 times subscribed, the company said on Tuesday (Jul 7).

    The international offering was 3.5 times subscribed, receiving interest for around 531.7 million shares for the 153.4 million shares available.

    The Singapore public offering was 9.4 times subscribed, with 3,805 valid applications for 87 million shares, amounting to S$66.1 million; 9.2 million shares were available for subscription.

    Shareholders include long-term institutional investors, insurers and fund managers part of Singapore’s Equity Market Development Programme, said Liaw Yit Ming, executive director and chief executive of Foundation Healthcare.

    Liaw noted that healthcare demand continues to be underpinned by long-term structural trends including an ageing population; rising demand for specialist-led care; the shift towards outpatient healthcare delivery; increasing emphasis on appropriate and value-based care; and growing healthcare digitalisation.

    The offering was underwritten by Jefferies Singapore, OCBC, UBS Singapore, DBS and UOB.

    Asean Intelligence

    Get insights into businesses across South-east Asia

    Get the free report

    Together with cornerstone commitments from 10 cornerstone investors, the IPO amounted to around S$242 million, assuming the over-allotment option is not exercised.

    Shares of the healthcare company are set to begin trading on the Singapore Exchange (SGX) at 9 am on Wednesday.

    Temasek-backed Foundation Healthcare announced on Jul 1 that it was seeking to raise S$242 million on the main board of the SGX, with an offer of 162.6 million shares at S$0.76 apiece.

    Net proceeds from the offering will mainly fund investments in and acquisitions of specialist practices and medical centres in Singapore; they will also go towards investments to support expansion plans in new markets, and general corporate and working capital purposes.

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Copyright SPH Media. All rights reserved.